CVD Prevention News
- EAS 2022 No Thrombotic Risk From Higher Lp(a) Levels
- ADA 2022 ADA Updates on Finerenone, SGLT2 Inhibitors, and Race-Based eGFR
- Time-Restricted Eating May Reduce CVD Risk After Breast Cancer
- EAS 2022 LDL-Lowering to Specific Targets May Offset Risk From High Lp(a)
- EAS 2022 CETP Inhibitors Finally Show Potential With Obicetrapib
- DDW 2022 ESG's Cardiometabolic Benefits Last 5 Years
- Very High HDL-C: Too Much of a Good Thing?
- Vascular Risk Factors for Dementia Vary With Age
- EAS 2022 Could Neutrophil Counts Predict Cardiovascular Outcomes?
- ESC-HF Moderate to High Alcohol Use May Push 'Pre-HF' Into Clinical HF
- Aspirin Links With CVD Cut in Patients With Kidney Disease
- A Cup of Cranberries a Day Tied to Better Memory
- Prostate Cancer Survival: Enzalutamide Edges Out Abiraterone
- Medicine, AI, and Bias: Will Bad Data Undermine Good Tech?
- Hormones Account for 10% of Lipid Changes After Menopause
- Keeping Thyroid Hormone Treatment On Target Is Key for the Heart
- Chronic Conditions Linked With Higher Risk for Fatal Drowning
- Resting Heart Rate Predicts Fitness Level
- DDW 2022 NAFLD in Lean Patients Linked to CVD Risk
- Greater Triglyceride-Glucose Index Variability Tied to CV Risk